Literature DB >> 21104383

Endocannabinoid signaling in neural plasticity.

Bradley E Alger1.   

Abstract

Plasticity refers to a physiologically measured change that may last for short or long periods of time. Endocannabinoids (ECBs) are prevalent throughout most of the brain, and modulate synaptic transmission in many ways. This chapter will focus on the roles of ECBs in neural plasticity in the mammalian brain. The topics covered can be divided loosely into two themes: how ECBs regulate synaptic plasticity, and how ECBs' actions themselves are regulated by neuronal activity. Because ECBs regulate synaptic plasticity, the modifiability of ECB mobilization constitutes a form of "metaplasticity" (as reported by Abraham and Bear (Trends Neurosci 19:126-130, 1996)), i.e., an upstream process that determines the nature and extent of synaptic plasticity. Many of their basic functions are still being discovered, and while there is consensus on large issues, many points of divergence exist as well. This chapter concentrates on developments in the roles of ECBs in synaptic plasticity that have come to light since the major review by Chevaleyre et al. (Annu Rev Neurosci 29:37-76, 2006).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21104383     DOI: 10.1007/978-3-540-88955-7_6

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  13 in total

1.  Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits.

Authors:  Karen M Crosby; Wataru Inoue; Quentin J Pittman; Jaideep S Bains
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

Review 2.  Rehabilitating the addicted brain with transcranial magnetic stimulation.

Authors:  Marco Diana; Tommi Raij; Miriam Melis; Aapo Nummenmaa; Lorenzo Leggio; Antonello Bonci
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 3.  Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Authors:  Maria Scherma; Anna Lisa Muntoni; Miriam Melis; Liana Fattore; Paola Fadda; Walter Fratta; Marco Pistis
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

4.  Tonic and transient endocannabinoid regulation of AMPAergic miniature postsynaptic currents and homeostatic plasticity in embryonic motor networks.

Authors:  Carlos Gonzalez-Islas; Miguel Angel Garcia-Bereguiain; Peter Wenner
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

5.  Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids.

Authors:  Jian-Yi Xu; Jian Zhang; Chu Chen
Journal:  J Physiol       Date:  2012-03-12       Impact factor: 5.182

Review 6.  Endocannabinoids in synaptic plasticity and neuroprotection.

Authors:  Jian-Yi Xu; Chu Chen
Journal:  Neuroscientist       Date:  2014-02-25       Impact factor: 7.519

Review 7.  Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  Annu Rev Neurosci       Date:  2016-02-24       Impact factor: 12.449

8.  Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease.

Authors:  Rongqing Chen; Jian Zhang; Yan Wu; Dongqing Wang; Guoping Feng; Ya-Ping Tang; Zhaoqian Teng; Chu Chen
Journal:  Cell Rep       Date:  2012-11-01       Impact factor: 9.423

9.  Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.

Authors:  Rongqing Chen; Jian Zhang; Ni Fan; Zhao-Qian Teng; Yan Wu; Hongwei Yang; Ya-Ping Tang; Hao Sun; Yunping Song; Chu Chen
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

10.  Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.

Authors:  Giuseppe Talani; David M Lovinger
Journal:  Alcohol       Date:  2015-10-27       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.